During the development process, the drug product manufacturing process often goes through a number of changes.
Measuring material characteristics and monitoring quality are essential for understanding risk.
Tracking changes can provide useful information later in development.
Merlin has worked with various companies, generating compactibility and compressibility assessments on batches of API from different campaigns to monitor for changes in compaction behaviour, creating a historical record of physical properties relating to manufacturability.
By continuing to use the site you agree to our privacy & cookies policy